Remove trial restrictions Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Colorcon
Merck
Express Scripts
Boehringer Ingelheim

Last Updated: May 17, 2022

CLINICAL TRIALS PROFILE FOR CARIPRAZINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Cariprazine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00488618 ↗ Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania Completed Gedeon Richter Ltd. Phase 2 2007-06-01 This is a study designed to evaluate the efficacy, safety, and tolerability of RGH-188 monotherapy in the treatment of acute mania. This study will be 5 weeks in duration; 3 weeks double-blind treatment and 2-weeks safety follow-up. All patients meeting the eligibility criteria will be randomized to one of two treatment groups: RGH-188 or placebo
NCT00488618 ↗ Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania Completed Forest Laboratories Phase 2 2007-06-01 This is a study designed to evaluate the efficacy, safety, and tolerability of RGH-188 monotherapy in the treatment of acute mania. This study will be 5 weeks in duration; 3 weeks double-blind treatment and 2-weeks safety follow-up. All patients meeting the eligibility criteria will be randomized to one of two treatment groups: RGH-188 or placebo
NCT00694707 ↗ Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia Completed Gedeon Richter Ltd. Phase 2 2008-06-30 This is a study to evaluate the safety, efficacy, and tolerability of cariprazine (RGH-188) relative to placebo in adult patients (18-60 years of age) with acute exacerbation of schizophrenia.
NCT00694707 ↗ Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia Completed Forest Laboratories Phase 2 2008-06-30 This is a study to evaluate the safety, efficacy, and tolerability of cariprazine (RGH-188) relative to placebo in adult patients (18-60 years of age) with acute exacerbation of schizophrenia.
NCT00839852 ↗ A Study of Cariprazine in Patients With Chronic Stable Schizophrenia Completed Gedeon Richter Ltd. Phase 2 2009-05-31 This is an outpatient study to evaluate the long-term safety, tolerability, and pharmacokinetics of cariprazine in patients with schizophrenia.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Cariprazine Hydrochloride

Condition Name

Condition Name for Cariprazine Hydrochloride
Intervention Trials
Schizophrenia 12
Major Depressive Disorder 7
Bipolar I Disorder 6
Bipolar Disorder 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Cariprazine Hydrochloride
Intervention Trials
Disease 16
Depression 13
Depressive Disorder 13
Schizophrenia 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Cariprazine Hydrochloride

Trials by Country

Trials by Country for Cariprazine Hydrochloride
Location Trials
United States 457
Ukraine 44
India 35
Romania 16
Russian Federation 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Cariprazine Hydrochloride
Location Trials
California 29
Texas 28
Ohio 27
Florida 25
New York 22
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Cariprazine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Cariprazine Hydrochloride
Clinical Trial Phase Trials
Phase 4 2
Phase 3 21
Phase 2 12
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Cariprazine Hydrochloride
Clinical Trial Phase Trials
Completed 23
Recruiting 5
Terminated 3
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Cariprazine Hydrochloride

Sponsor Name

Sponsor Name for Cariprazine Hydrochloride
Sponsor Trials
Forest Laboratories 22
Gedeon Richter Ltd. 17
Allergan 10
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Cariprazine Hydrochloride
Sponsor Trials
Industry 52
Other 7
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Colorcon
Mallinckrodt
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.